PolyPid (PYPD) Non Operating Interest Expenses (2019 - 2021)
PolyPid's (PYPD) quarterly Non Operating Interest Expenses came in at -$152000.0 in Q4 2021, up 55.16% year-over-year from -$97962.0 in Q4 2020, and down 17.83% quarter-over-quarter from -$129000.0 in Q3 2021.
Analysis
PolyPid (PYPD) Non Operating Interest Expenses (2019 - 2021) Analysis & Trends
PolyPid has disclosed Non Operating Interest Expenses across 3 years of filings, most recently posting -$152000.0 for Q4 2021.
- In Q4 2021, Non Operating Interest Expenses rose 55.16% year-over-year to -$152000.0; the TTM figure through Dec 2021 stood at -$773000.0 (down 108.97% YoY), while the FY2025 annual figure was $1.2 million, down 20.39% from the prior year.
- Non Operating Interest Expenses came in at -$152000.0 for Q4 2021 at PolyPid, down from -$129000.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $9.7 million in Q2 2020 to a low of -$5.0 million in Q2 2019.
- Average Non Operating Interest Expenses over 3 years is $398375.0, with a median of -$185500.0 recorded in 2020.
- Year-over-year, Non Operating Interest Expenses soared 294.61% in 2020 and sank 101.57% in 2021.
- Over 3 years, Non Operating Interest Expenses stood at -$548000.0 in 2019, then surged by 38.14% to -$339000.0 in 2020, then surged by 55.16% to -$152000.0 in 2021.
- Per Business Quant data, the three most recent Non Operating Interest Expenses figures were -$152000.0 in Q4 2021, -$129000.0 in Q3 2021, and -$153000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | PolyPid | 85.52 Mn | 78.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -152,000.00 |
| Sep 30, 2021 | -129,000.00 |
| Jun 30, 2021 | -153,000.00 |
| Dec 31, 2020 | -339,000.00 |
| Sep 30, 2020 | -218,000.00 |
| Jun 30, 2020 | 9.72 Mn |
| Dec 31, 2019 | -548,000.00 |
| Jun 30, 2019 | -5.00 Mn |